⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27415328 | 1.00 | ALPL (0.36) | — | |
| SCHEMBL16559 | 1.00 | — | — | |
| SCHEMBL16558 | 1.00 | — | — | |
| SCHEMBL9172235 | 0.97 | HIF1A (0.38) | — | |
| Piperazine SCHEMBL7612531 | 0.97 | HIF1A (0.38) | — | |
| Hydrochloric Acid SCHEMBL483495 | 0.97 | — | — | |
| SCHEMBL8200112 | 0.97 | HIF1A (0.38) | — | |
| Ethane SCHEMBL1785139 | 0.97 | — | — | |
| SCHEMBL17344128 | 0.97 | HIF1A (0.38) | — | |
| SCHEMBL8200668 | 0.97 | HIF1A (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1664 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119842067-A | Porous crystal polymer and preparation method and application thereof | 济南大学 | 2025-04-18 | — | — | CN | claimed |
| CN-119080649-A | Organic crystalline piezoelectric material and preparation method thereof | 南昌大学 | 2024-12-06 | — | — | CN | claimed |
| CN-118994037-A | Circular polarization luminous chiral enantiomer monocrystal and preparation method thereof | 江苏锡沂高新材料产业技术研究院有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-118446381-B | Service area full scene-oriented AI intelligent operation system | 宁波朗达科技有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-118446381-A | Service area full scene-oriented AI intelligent operation system | 宁波朗达科技有限公司 | 2024-08-06 | — | — | CN | claimed |
| CN-113549018-B | Protein kinase inhibitor and derivative thereof, preparation method, pharmaceutical composition and application | 中国药科大学 | 2024-02-27 | — | — | CN | claimed |
| CN-112794855-A | N-aryl pyrimidine-4-amine derivative and application thereof | 中国药科大学 | 2021-05-14 | — | — | CN | claimed |
| CN-111675700-A | Preparation method of novel anti-cancer drug AZD3759 | 通化师范学院 | 2020-09-18 | — | — | CN | claimed |
| CN-111662273-A | Preparation method of tyrosine kinase inhibitor AZD3759 | 通化师范学院 | 2020-09-15 | — | — | CN | claimed |
| WO-2015106012-A1 | AZAINDOLE DERIVATIVES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-07-16 | — | — | WO | claimed |
| CN-100334082-C | Process for preparing 2-methylpiperazine derivatives | BIOVITRUM AB (SE) | 2007-08-29 | — | — | CN | claimed |
| US-7129354-B2 | Process for the preparation of stable acid addition salt of 2,3-disubstituted pyrazine compounds | BIOVITRUM AB (SE) | 2006-10-31 | — | — | US | claimed |
| EP-1529043-B1 | Process for the preparation of 2-methyl piperazine derivatives. | BIOVITRUM AB (SE) | 2006-08-02 | — | — | EP | claimed |
| US-20060142578-A1 | Novel process | BIOVITRUM AB, A SWEDEN CORPORATION | 2006-06-29 | — | — | US | claimed |
| CN-1662523-A | Novel process | BIOVITRUM AB (SE) | 2005-08-31 | — | — | CN | claimed |
| CN-1202088-C | Process for simultaneously producing S-(+)-2-methylpiperazine and R-(-)-2-methylpiperazine by stepwise salification | GUANGTONG MEDICINE CHEMICAL IN (CN) | 2005-05-18 | — | — | CN | claimed |
| EP-1529043-A1 | NOVEL PROCESS | Biovitrum AB (SE) | 2005-05-11 | — | — | EP | claimed |
| US-20040038981-A1 | Novel Process | PROXIMAGEN NEUROSCIENCE PLC (GB) | 2004-02-26 | — | — | US | claimed |
| WO-2004000829-A1 | NOVEL PROCESS | BIOVITRUM AB (SE) | 2003-12-31 | — | — | WO | claimed |
| CN-1456553-A | Process for simultaneously producing S-(+)-2-methylpiperazine and R-(-)-2-methylpiperazine by stepwise salification | GUANGTONG MEDICINE CHEMICAL IN (CN) | 2003-11-19 | — | — | CN | claimed |